← Back to Search

Behavioral Intervention

Virtual Rehabilitation for Cancer Survivors

N/A
Recruiting
Led By Jennifer Jones, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
An indication for cancer rehabilitation (WHO-DAS score >5)
Age 18 years or older
Must not have
Impaired functional status that would preclude rehabilitation (PRFS >3)
Indication of major depressive disorder (PHQ-2 >3)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests an 8-week virtual cancer rehab program to help cancer survivors with physical and social functioning, anxiety, work, and quality of life. Researchers will study effectiveness and potential factors that may affect successful implementation.

Who is the study for?
This trial is for cancer survivors aged 18+ who've finished primary treatment within the last 2 years. It's open to those with breast, colorectal, head and neck cancers or lymphoma if they're responding well to ongoing therapies like immunotherapy. Participants need good enough English for the intervention, internet access, and a WHO-DAS score over 5 indicating a need for rehab.
What is being tested?
The CaRE@Home program is being tested in this study. It's an 8-week virtual rehabilitation designed to help cancer survivors manage impairments related to their condition. The effectiveness of this online program on disability levels and other aspects like anxiety and quality of life will be measured across several Canadian centers.
What are the potential side effects?
Since CaRE@Home is a non-medical virtual rehab intervention focusing on exercise and support, it doesn't have typical drug side effects. However, participants may experience general discomfort or fatigue associated with physical activity during rehabilitation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need help because my daily activities are affected by my cancer.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My health condition prevents me from participating in rehabilitation.
Select...
I have been diagnosed with major depression.
Select...
I have a neurological condition that significantly affects my thinking, memory, or language skills.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Disability
Secondary study objectives
30-second sit to stand test
Anxiety
Demographics
+11 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CaRE@Home interventionExperimental Treatment1 Intervention
Group II: Usual Care groupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,521 Previous Clinical Trials
502,916 Total Patients Enrolled
Jennifer Jones, PhDPrincipal InvestigatorUHN Princess Margaret Cancer Centre
1 Previous Clinical Trials
117 Total Patients Enrolled

Media Library

CaRE@Home intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05898789 — N/A
Lymphoproliferative Disease Research Study Groups: CaRE@Home intervention, Usual Care group
Lymphoproliferative Disease Clinical Trial 2023: CaRE@Home intervention Highlights & Side Effects. Trial Name: NCT05898789 — N/A
CaRE@Home intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05898789 — N/A
~106 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top